Compounds > lorazepam

lorazepam and methylphenidate

lorazepam has been researched along with methylphenidate in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (8.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (41.67)	29.6817
2010's	6 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, MH; Acree, WE; Ibrahim, A	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Berchou, R; Chayasirisobhon, S; Green, V; Mason, K	1
Camacho, A; Ng, B	1
Brignell, CM; Curran, HV; Rosenthal, J	1
Baier, AR; Coons, EE; Fingesten, A; Ockert, DM; Volpicelli, JR	1
Dempsey, M	1
Exadaktylos, A; Fattinger, K; Marti, G; Zimmermann, H	1

Reviews

1 review(s) available for lorazepam and methylphenidate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for lorazepam and methylphenidate

Article	Year
Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:7 Topics: Adolescent; Adult; Anti-Anxiety Agents; Arousal; Central Nervous System Stimulants; Double-Blind Method; Emotions; Female; Humans; Lorazepam; Male; Memory; Methylphenidate	2007

Other Studies

10 other study(ies) available for lorazepam and methylphenidate

Article	Year
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
The pharmacodynamic properties of lorazepam and methylphenidate drugs on event-related potentials and power spectral analysis in normal subjects. Clinical EEG (electroencephalography), 1986, Volume: 17, Issue:4 Topics: Adolescent; Adult; Cognition; Electroencephalography; Female; Humans; Lorazepam; Male; Membrane Potentials; Methylphenidate; Middle Aged; Time Factors	1986
Methylphenidate for alpha-interferon induced depression. Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:5 Topics: Affect; Aged; Antineoplastic Agents; Central Nervous System Stimulants; Depressive Disorder; Humans; Hypnotics and Sedatives; Interferon alpha-2; Interferon-alpha; Lorazepam; Male; Melanoma; Methylphenidate; Psychiatric Status Rating Scales; Pyridines; Recombinant Proteins; Trazodone; Zolpidem	2006
A nonopioid procedure for outpatient opioid detoxification. Journal of addiction medicine, 2011, Volume: 5, Issue:2 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clonidine; Drug Therapy, Combination; Female; GABA Modulators; Heroin Dependence; Humans; Lorazepam; Male; Methylphenidate; Middle Aged; Modafinil; New York; Opioid-Related Disorders; Outpatients; Selective Serotonin Reuptake Inhibitors; Substance Abuse Treatment Centers; Trazodone; Treatment Outcome; Young Adult	2011
A true mystery diagnosis. Journal of the Mississippi State Medical Association, 2011, Volume: 52, Issue:10 Topics: Adolescent; Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Confusion; Diagnosis, Differential; Disorders of Excessive Somnolence; Humans; Hyperphagia; Hypnotics and Sedatives; Kleine-Levin Syndrome; Lorazepam; Male; Methylphenidate; Oxcarbazepine	2011
Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland. Human & experimental toxicology, 2013, Volume: 32, Issue:3 Topics: Administration, Intranasal; Adult; Central Nervous System Stimulants; Humans; Hypnotics and Sedatives; Lorazepam; Male; Methylphenidate; Movement Disorders; Switzerland; Young Adult	2013